Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emily A. Siegrist & Joseph Sassine. (2023) Letermovir and new horizons in prevention of post-transplant CMV. Expert Review of Clinical Pharmacology 0:0, pages 1-3.
Read now
Read now
Giuseppe Gerna, Daniele Lilleri & Fausto Baldanti. (2019) An overview of letermovir: a cytomegalovirus prophylactic option. Expert Opinion on Pharmacotherapy 20:12, pages 1429-1438.
Read now
Read now
Guy El Helou & Raymund R Razonable. (2019) Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infection and Drug Resistance 12, pages 1481-1491.
Read now
Read now
Articles from other publishers (14)
TERRI LYNN SHIGLE & VICTORIA WEHR HANDY. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies
145
165
.
Ella J Ariza-Heredia, Drew J Winston, Scott D Rowley, Kathleen Mullane, Pranatharthi Chandrasekar, Parameswaran Hari, Robin K Avery, Karl S Peggs, Deepali Kumar, Rajneesh Nath, Per Ljungman, Sherif B Mossad, Lynn El Haddad, Dimpy P Shah, Ying Jiang, Fareed Khawaja, Sanjeet Dadwal, Ted Blanchard & Roy F Chemaly. (2023) Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infectious Diseases 10:8.
Crossref
Crossref
Andreu Gazquez Casals, Alex J. Berkowitz, Alice J. Yu, Hope E. Waters, Daniel V. Schiavone, Diana M. Kapkayeva, Lynda A. Morrison & Ryan P. Murelli. (2023) Antiviral activity of amide-appended α-hydroxytropolones against herpes simplex virus-1 and -2. RSC Advances 13:13, pages 8743-8752.
Crossref
Crossref
Jana K. Dickter, Justine A. Ross, Jasmine M. Zain, Bernard R. Tegtmeier, Brian V. Lee & Sanjeet S. Dadwal. (2022) Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy. Journal of Clinical Pharmacy and Therapeutics 47:5, pages 699-702.
Crossref
Crossref
David Beauvais, Christine Robin, Anne Thiebaut, Sophie Alain, Valérie Coiteux, Sophie Ducastelle-Lepretre, Ambroise Marçais, Patrice Ceballos, Alienor Xhaard, Rabah Redjoul, Stéphanie Nguyen, Eolia Brissot, Magalie Joris, Pascal Turlure, Marie-Thérèse Rubio, Patrice Chevallier, Nathalie Bénard, Camille Liautard & Ibrahim Yakoub-Agha. (2022) Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program. Journal of Clinical Virology 148, pages 105106.
Crossref
Crossref
Kye Ryeong Park, Young-Eui Kim, Amen Shamim, Shuang Gong, Soo-Han Choi, Kyeong Kyu Kim, Yae-Jean Kim & Jin-Hyun Ahn. (2022) Analysis of Novel Drug-Resistant Human Cytomegalovirus DNA Polymerase Mutations Reveals the Role of a DNA-Binding Loop in Phosphonoformic Acid Resistance. Frontiers in Microbiology 13.
Crossref
Crossref
David Beauvais, Elodie Drumez, Didier Blaise, Régis Peffault de Latour, Edouard Forcade, Patrice Ceballos, Anne Uyttebroeck, Hélène Labussière, Stéphanie Nguyen, Jean-Henri Bourhis, Patrice Chevallier, Anne Thiebaut, Xavier Poiré, Sébastien Maury, Eric Deconinck, Thomas Cluzeau, Eolia Brissot, Anne Huynh, Marie-Thérèse Rubio, Alain Duhamel & Ibrahim Yakoub-Agha. (2020) Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study. Bone Marrow Transplantation 56:6, pages 1305-1315.
Crossref
Crossref
Adnan Alsumali, Roy F. Chemaly, Jonathan Graham, Yiling Jiang, Sanjay Merchant, LaStella Miles, Jonathan Schelfhout, Joe Yang & Yuexin Tang. (2020) Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective. Journal of Medical Virology 93:6, pages 3786-3794.
Crossref
Crossref
Rajat Bansal, Christian A Gordillo, Rachel Abramova, Amer Assal, Markus Y Mapara, Marcus R Pereira & Ran Reshef. (2020) Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease. Transplant Infectious Disease 23:2.
Crossref
Crossref
Jocelyne Piret & Guy Boivin. 2021. Viral Replication Enzymes and their Inhibitors Part B. Viral Replication Enzymes and their Inhibitors Part B
79
132
.
Yogesh Kumar, Harvijay Singh & Chirag N. Patel. (2020) In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health 13:9, pages 1210-1223.
Crossref
Crossref
Tara Keil, Dongmei Liu, Megan Lloyd, Wanda Coombs, Jennifer Moffat & Robert Visalli. (2020) DNA Encapsidation and Capsid Assembly Are Underexploited Antiviral Targets for the Treatment of Herpesviruses. Frontiers in Microbiology 11.
Crossref
Crossref
Laura K. Whited, Victoria W. Handy, Chitra Hosing & Eric Chow. (2020) Incidence of viral and fungal complications after utilization of alternative donor sources in hematopoietic cell transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:8, pages 773-787.
Crossref
Crossref
Michael McVoy, Edgar Tenorio & Lawrence Kauvar. (2018) A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I). International Journal of Molecular Sciences 19:12, pages 3982.
Crossref
Crossref